Birth Rate in Conservative Monitoring of Pregnancy Beyond the Date of Birth.
NCT ID: NCT02680093
Last Updated: 2016-02-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2016-02-29
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
additional medical data will be collected from the patient medical record.- demographic data, and all the routine prenatal medical care the women will receive up to the delivery.and delivery outcomes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Is It Possible to Predict Pre Term Labor by Measuring Cervical Length in the Non-pregnant Uterus?
NCT01340352
Vaginal Progesterone Versus Cervical Cerclage for Pregnant Women With Short Cervix and History of PTL and/or MTM
NCT02673359
Prediction of Preterm Delivery with Serial Cervical Length Measurements After Threatened Preterm Labor
NCT05044143
Cervix Monitor for Elasticity and Length Measurements
NCT03199079
Cervical Volume and Prediction of Preterm Labor
NCT06190496
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cervical length in pregnant women.
Pregnant Women beyond the date of birth in conservative monitoring and prenatal follow-up. will be followed while coming to routine monitoring.
physiological parameter of cervical length will be measured as the differential predictor to determine their due date.
Cervical length in pregnant women.
Pregnant Women beyond the date of birth. will be followed while coming to routine monitoring. physiological parameter of cervical length will be measured as the differential predictor to determine their due date. the cervical length will be measured as part of routine gynecologic examination to women who come for routine over due date follow up.
additional medical data will be collected from the patient medical record.- demographic data, and all the routine prenatal medical care the women will receive up to the delivery.and delivery out comes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cervical length in pregnant women.
Pregnant Women beyond the date of birth. will be followed while coming to routine monitoring. physiological parameter of cervical length will be measured as the differential predictor to determine their due date. the cervical length will be measured as part of routine gynecologic examination to women who come for routine over due date follow up.
additional medical data will be collected from the patient medical record.- demographic data, and all the routine prenatal medical care the women will receive up to the delivery.and delivery out comes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Individual fetus
3. The dating of gestational age based on first- trimester ultrasonography or by last menstrual
4. Gestational age between 39 weeks and 0 days to 41 weeks and 6 days .
5. The pregnant women is not in pain ( VAS \<3 ) while signing on consent to participate.
6. Normal fetal monitoring measures and Sonar
7. Expectant mother is in active labor
8. Consent to participate
Exclusion Criteria
2. Without accurate dating of gestational age based on first- trimester ultrasonography or by last menstrual
3. Indicators for abnormal fetal monitoring and / or Sonar
4. Active labor
5. pain ( VAS \> = 3 )
6. Expectant mother does not agree to participate or delivery if consent was given earlier
18 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tel-Aviv Sourasky Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
yariv yogev, professor
Role: PRINCIPAL_INVESTIGATOR
Tel Aviv Medical Center
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0602-15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.